Lymphomas can develop from B cells chronically helped by idiotype-specific T cells

Journal of Experimental Medicine

Volumn 204, Issue 5, 2007, Pages 1181-1191

  Zangani, Michael M ^a   Frøyland, Marianne ^a   Gao, Yue Qiu ^a,d   Meza Zepeda, Leonardo A ^b   Kutok, Jeffery L ^c   Thompson, Keith M ^a   Munthe, Ludvig A ^a   Bogen, Bjarne ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Shanghai Shuguang Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN IDIOTYPE; INTERLEUKIN 3 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL LINEAGE; CELL TYPE; CONTROLLED STUDY; CYTOGENETICS; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; LYMPHOMA; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; BASE SEQUENCE; FLOW CYTOMETRY; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN IDIOTYPES; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 34249000978     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20061220     Document Type: Article

References (56)

1. Parker, D.C. 1993. T cell-dependent B cell activation. Annu. Rev. Immunol. 11:331-360.
2. Kuppers, R. 2005. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer. 5:251-262.
3. Morse, H.C., III, J.F. Kearney, P.G. Isaacson, M. Carroll, T.N. Fredrickson, and E.S. Jaffe. 2001. Cells of the marginal zone - origins, function and neoplasia. Leuk. Res. 25:169-178.
4. Ansell, S.M., M. Stenson, T.M. Habermann, D.F. Jelinek, and T.E. Witzig. 2001. CD4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. J. Clin. Oncol. 19:720-726.
5. Dave, S.S., G. Wright, B. Tan, A. Rosenwald, R.D. Gascoyne, W.C. Chan, R.I. Fisher, R.M. Braziel, L.M. Rimsza, T.M. Grogan, et al. 2004. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 351:2159-2169.
6. Monti, S., K.J. Savage, J.L. Kutok, F. Feuerhake, P. Kurtin, M. Mihm, B. Wu, L. Pasqualucci, D. Neuberg, R.C.T. Aguiar, et al. 2005. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood. 105:1851-1861.
7. Stevenson, G.T., and F.K. Stevenson. 1975. Antibody to a molecularly-defined antigen confined to a tumour cell surface. Nature. 254:714-716.
8. Weiss, S., and B. Bogen. 1989. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA. 86:282-286.
9. Weiss, S., and B. Bogen. 1991. MHC class II-restricted presentation of intracellular antigen. Cell. 64:767-776.
10. Munthe, L.A., J.A. Kyte, and B. Bogen. 1999. Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4+ T cells in vivo. Eur. J. Immunol. 29:4043-4052.
11. Bogen, B., B. Malissen, and W. Haas. 1986. Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur. J. Immunol. 16:1373-1378.
12. Rudensky, A.Y., P. Preston-Hurlburt, B. K.al-Ramadi, J. Rothbard, and C.A.J. Janeway. 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature. 359:429-431.
13. Chicz, R.M., R.G. Urban, J.C. Gorga, D.A. Vignali, W.S. Lane, and J.L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27-47.
14. Newcomb, J.R., and P. Cresswell. 1993. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. J. Immunol. 150:499-507.
15. Lippolis, J.D., F.M. White, J.A. Marto, C.J. Luckey, T.N. Bullock, J. Shabanowitz, D.F. Hunt, and V.H. Engelhard. 2002. Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J. Immunol. 169:5089-5097.
16. Bogen, B., T. Jorgensen, and K. Hannestad. 1985. T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region. Eur. J. Immunol. 15:278-281.
17. Bogen, B., Z. Dembic, and S. Weiss. 1993. Clonal deletion of specific thymocytes by an immunoglobulin idiotype. EMBO J. 12:357-363.
18. Eyerman, M.C., X. Zhang, and L.J. Wysocki. 1996. T cell recognition and tolerance of antibody diversity. J. Immunol. 157:1037-1046.
19. Snodgrass, H.R., A.M. Fisher, E. Bruyns, and B. Bogen. 1992. Restricted alpha/beta receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: selection for CDR3-related sequences. Eur. J. Immunol. 22:2169-2172.
20. Bogen, B., and S. Weiss. 1993. Processing and presentation of idiotypes to MHC-restricted T cells. Int. Rev. Immunol. 10:337-355.
21. Bogen, B., and S. Weiss. 1991. A rearranged lambda 2 light gene chain retards but does not exclude kappa and lambda 1 expression. Eur. J. Immunol. 21:2391-2395.
22. Bogen, B., L. Gleditsch, S. Weiss, and Z. Dembic. 1992. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities. Eur. J. Immunol. 22:703-709.
23. Munthe, L.A., A. Os, M. Zangani, and B. Bogen. 2004. MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production. J. Immunol. 172:7476-7484.
24. + T cells reactive to an immunoglobulin variable region. J. Exp. Med. 200:1-11.
25. Morse, H.C., III, M.R. Anver, T.N. Fredrickson, D.C. Haines, A.W. Harris, N.L. Harris, E.S. Jaffe, S.C. Kogan, I.C.M. MacLennan, P.K. Pattengale, and J.M. Ward. 2002. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood. 100:246-258.
26. Fredrickson, T.N., K. Lennert, S.K. Chattopadhyayy, H.C. Morse III, and J.W. Hartley. 1999. Splenic marginal zone lymphomas of mice. Am. J. Pathol. 154:805-812.
27. Shin, M.S., T.N. Fredrickson, J.W. Hartley, T. Suzuki, K. Akagi, and H.C. Morse III. 2004. High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res. 64:4419-4427.
28. Munthe, L.A., A. Corthay, A. Os, M. Zangani, and B. Bogen. 2005. Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig v region-specific T cells. J. Immunol. 175:2391-2400.
29. Barrett, M.T., A. Scheffer, A. Ben-Dor, N. Sampas, D. Lipson, R. Kincaid, P. Tsang, B. Curry, K. Baird, P.S. Meltzer, et al. 2004. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc. Natl. Acad. Sci. USA. 101:17765-17770.
30. Lauritzsen, G.F., S. Weiss, Z. Dembic, and B. Bogen. 1994. Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. Proc. Natl. Acad. Sci. USA. 91:5700-5704.
31. Corthay, A., D.K. Skovseth, K.U. Lundin, E. Rosjo, H. Omholt, P.O. Hofgaard, G. Haraldsen, and B. Bogen. 2005. Primary antitumor immune response mediated by CD4+ T cells. Immunity. 22:371-383.
32. Rosa, D., G. Saletti, G.E. De, F. Zorat, C. Comar, U. D'Oro, S. Nuti, M. Houghton, V. Barnaba, G. Pozzato, and S. Abrignani. 2005. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. USA. 102:18544-18549.
33. Bende, R.J., W.M. Aarts, R.G. Riedl, D. de Jong, S.T. Pals, and C.J.M. van Noesel. 2005. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201:1229-1241.
34. Leadbetter, E.A., I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:603-607.
35. Martin, F., A.M. Oliver, and J.F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 14:617-629.
36. Pillai, S., A. Cariappa, and S.T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23:161-196.
37. Engel, H., B. Bogen, U. Muller, J. Andersson, A. Rolink, and S. Weiss. 1998. Expression level of a transgenic lambda2 chain results in isotype exclusion and commitment to B1 cells. Eur. J. Immunol. 28:2289-2299.
38. Kretschmer, K., A. Jungebloud, J. Stopkowicz, T. Kleinke, R. Hoffmann, and S. Weiss. 2003. The selection of marginal zone B cells differs from that of B-1a cells. J. Immunol. 171:6495-6501.
39. Attanavanich, K., and J.F. Kearney. 2004. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 172:803-811.
40. Ghia, P., G. Strola, L. Granziero, M. Geuna, G. Guida, F. Sallusto, N. Ruffing, L. Montagna, P. Piccoli, M. Chilosi, and F. Caligaris-Cappio. 2002. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur. J. Immunol. 32:1403-1413.
41. van den Berg, A., L. Visser, and S. Poppema. 1999. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am. J. Pathol. 154:1685-1691.
42. Johnson, P.W., S.M. Watt, D.R. Betts, D. Davies, S. Jordan, A.J. Norton, and T.A. Lister. 1993. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood. 82:1848-1857.
43. Veronese, M.L., A. Veronesi, E. D'Andrea, A. Del Mistro, S. Indraccolo, M.R. Mazza, M. Mion, R. Zamarchi, C. Menin, M. Panozzo, et al. 1992. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J. Exp. Med. 176:1763-1767.
44. Murphy, W.J., S. Funakoshi, M. Beckwith, S.E. Rushing, D.K. Conley, R.J. Armitage, W.C. Fanslow, H.C. Rager, D.D. Taub, and F.W. Ruscetti. 1995. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes. Blood. 86:1946-1953.
45. Umetsu, D.T., L. Esserman, T.A. Donlon, R.H. DeKruyff, and R. Levy. 1990. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J. Immunol. 144:2550-2557.
46. Egle, A., A.W. Harris, M.L. Bath, L. O'Reilly, and S. Cory. 2004. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood. 103:2276-2283.
47. Dunn, G.P., L.J. Old, and R.D. Schreiber. 2004. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22:329-360.
48. Nishimura, T., K. Iwakabe, M. Sekimoto, Y. Ohmi, T. Yahata, M. Nakui, T. Sato, S. Habu, H. Tashiro, M. Sato, and A. Ohta. 1999. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J. Exp. Med. 190:617-628.
49. Bogen, B. 1996. Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma. Eur. J. Immunol. 26:2671-2679.
50. Read, S., and F. Powrie. 2001. CD4(+) regulatory T cells. Curr. Opin. Immunol. 13:644-649.
51. Hill, N., and N. Sarvetnick. 2002. Cytokines: promoters and dampeners of autoimmunity. Curr. Opin. Immunol. 14:791-797.
52. Wen, Y.J., and S.H. Lim. 1997. T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma. Eur. J. Immunol. 27:1043-1047.
53. Rezvany, M.R., M. Jeddi-Tehrani, H. Rabbani, U. Ruden, L. Hammarstrom, A. Osterborg, H. Wigzell, and H. Mellstedt. 2000. Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia. Br. J. Haematol. 111:230-238.
54. Yi, Q., I. Eriksson, W. He, G. Holm, H. Mellstedt, and A. Osterborg. 1997. Idiotype-specific T lymphocytes in monoclonal gammopathies: evidence for the presence of CD4+ and CD8+ subsets. Br. J. Haematol. 96:338-345.
55. Fagerberg, J., Q. Yi, D. Gigliotti, U. Harmenberg, U. Ruden, B. Persson, A. Osterborg, and H. Mellstedt. 1999. T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma. Int. J. Cancer. 80:671-680.
56. Wang, Z., M. Raifu, M. Howard, L. Smith, D. Hansen, R. Goldsby, and D. Ratner. 2000. Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3′ to 5′ exonuclease activity. J. Immunol. Methods. 233:167-177.